El-Mazny, A., M. El-Sharkawy, and A. Hassan, "A prospective randomized clinical trial comparing immediate versus delayed removal of urinary catheter following elective cesarean section.", Eur J Obstet Gynecol Reprod Biol. , vol. 181, pp. 111-114, 2014.
El-Mazny, A., N. Abou-Salem, and H. ElShenoufy, "Doppler study of uterine hemodynamics in women with unexplained infertility.", Eur J Obstet Gynecol Reprod Biol. , vol. 171, issue 1, pp. 84-87, 2013.
El-Mazny, A., and N. Abou-Salem, "Anti-Müllerian hormone and antral follicle count for prediction of ovarian stimulation response in polycystic ovary syndrome.", Gynecol Endocrinol. , vol. 29, issue 9, pp. 826-829, 2013.
Al-Sawaf, A., A. El-Mazny, and A. Shohayeb, "A randomised controlled trial of sublingual misoprostol and intramuscular oxytocin for prevention of postpartum haemorrhage.", Journal of Obstetrics & Gynaecology, vol. 33, issue 3, pp. 277-279, 2013. AbstractWebsite

This study aims to evaluate the efficacy and side-effects of 200 μg sublingual misoprostol vs 5 IU i.m. oxytocin, administered immediately following cord clamping in normal non-augmented vaginal delivery, in prevention of postpartum haemorrhage (PPH). A total of 104 women were randomised into three groups: misoprostol group (28 patients); oxytocin group (37 patients) and control group (39 patients). Misoprostol and oxytocin significantly minimised the blood loss during the third stage of labour and reduced the need for additional treatments for PPH as compared with the control group. Oxytocin was more effective than misoprostol in minimising blood loss and the need for additional uterotonic treatments. However, a significant decrease in systolic and diastolic blood pressure, associated with tachycardia was observed in the oxytocin group. In conclusion, sublingual misoprostol appears to be less effective than i.m. oxytocin in the prevention of PPH; however, it has the potential advantages of being easily used, cost-effective and stable at room temperature. Therefore, sublingual misoprostol is still a feasible drug for routine management of third stage, especially in areas with limited medical facilities.

Abou-Salem, N., A. Elmazny, and W. El-Sherbiny, "Value of 3-Dimensional Sonohysterography for Detection of Intrauterine Lesions in Women with Abnormal Uterine Bleeding", Journal of Minimally Invasive Gynecology, vol. 17, no. 2, pp. 200 - 204, 2010. AbstractWebsite

Study Objective To compare 2-dimensional (2D) sonohysterography (SHG) and 3D-SHG with saline solution infusion vs diagnostic hysteroscopy for investigation of intrauterine lesions in perimenopausal and postmenopausal women with abnormal uterine bleeding. Design Comparative observational cross-sectional study (Canadian Task Force classification II-1). Setting University hospital. Patients Fifty perimenopausal and 20 postmenopausal women with abnormal intrauterine bleeding with clinically or ultrasonically suspected intrauterine lesions. Interventions Conventional 2D- and 3D ultrasonography and 2D- and 3D-SHG with saline solution infusion followed by diagnostic hysteroscopy, and endometrial curettage or subsequent operative treatment (e.g., hysterectomy, myomectomy, or polypectomy). Ultrasonographic and hysteroscopic findings were compared with histopathologic findings. Measurements and Main Results For 2D-SHG, sensitivity, specificity, positive predictive value, negative predictive value, overall accuracy, likelihood ratio for a positive result, and likelihood ratio for a negative result were 79%, 72%, 89%, 54%, 76%, 2.82, and 0.29, respectively, and for 3D-SHG, were 92%, 89%, 96%, 80%, 91%, 8.36, and 0.09, respectively; and for diagnostic hysteroscopy, were 94%, 89%, 96%, 84%, 93%, 8.55, and 0.07, respectively. Thus, 3D-SHG was superior to 2D \{SHG\} (p = .02) and comparable to diagnostic hysteroscopy (p = .75) for diagnosis of intrauterine lesions. Conclusion 3D-SHG can be used in the initial investigation of intrauterine lesions in perimenopausal and postmenopausal women with abnormal uterine bleeding before resorting to invasive procedures such as diagnostic hysteroscopy. Further studies of computer-reconstructed 3D-SHG virtual hysteroscopy are recommended.

El-Mazny, A., N. Abou-Salem, W. El-Sherbiny, and W. Saber, "Outpatient hysteroscopy: a routine investigation before assisted reproductive techniques?", Fertility and Sterility, vol. 95, no. 1, pp. 272 - 276, 2011. AbstractWebsite

Objective To evaluate the importance of subjecting the patient to an outpatient (office) hysteroscopy (OH) before assisted reproductive techniques (ART) and patient compliance, possible side effects, and complications of the procedure. Design Comparative observational cross-sectional study. Setting University hospital. Patient(s) One hundred fifty-two patients attending the outpatient infertility clinic for pre-ART (IVF/intracytoplasmic sperm injection [ICSI]-ET) investigations, with normal uterine findings on hysterosalpingography (HSG). Intervention(s) Transvaginal sonography (TVS) and \{OH\} (using a rigid, 30-degree, 4-mm hysteroscope) by the vaginoscopic “no touch” technique. Main Outcome Measure(s) Diagnostic value and compliance of OH. Result(s) The procedure was successful in 145 patients (95.4%); 51 of them (35.2%) had previous \{ART\} failures. Abnormal hysteroscopic findings were observed in 48 women (33.1%), in which endometrial polyp, submucous myoma, and intrauterine adhesions were the most common findings. The \{TVS\} was specific (100%) but not sensitive (41.7%) compared with OH. Abnormal hysteroscopic findings were significantly higher in patients with previous \{ART\} failure(s). The procedure was acceptable in almost all patients with no reported complications. Conclusion(s) The \{OH\} should be part of the infertility workup before \{ART\} even in patients with normal \{HSG\} and/or TVS. This is especially relevant in cases with prior failed \{ART\} cycles.

El-Sherbiny, W., A. Soliman, and A. El-Mazny, "Elevated Serum-Soluble Fas in Preeclampsia: Correlation with Clinical, Laboratory, and Doppler Parameters", Hypertension in Pregnancy, vol. 30, no. 2, pp. 221-230, 2011. AbstractWebsite
n/a
El-Mazny, A., N. Abou-Salem, W. El-Sherbiny, and A. El-Mazny, "Insulin resistance, dyslipidemia, and metabolic syndrome in women with polycystic ovary syndrome", International Journal of Gynecology & Obstetrics, vol. 109, no. 3, pp. 239 - 241, 2010. AbstractWebsite

Objective To investigate the association of insulin resistance with dyslipidemia and metabolic syndrome (MBS) in women with polycystic ovary syndrome (PCOS). Methods Fasting glucose (G), insulin (I), and lipid levels were measured in 50 infertile women with PCOS. A fasting G/I ratio of 4.5 or less (n = 29) defined insulin resistance (IR). Results The mean levels of total cholesterol (P < 0.001), low-density lipoprotein (P = 0.02), and triglycerides (P < 0.001) were significantly higher and the mean levels of high-density lipoprotein were significantly lower (P < 0.001) in the İR\} group. The prevalence of \{MBS\} (P = 0.02) and obesity (P = 0.04), hypertension (P = 0.02), fasting hyperglycemia (P = 0.03), low high-density lipoprotein levels (P = 0.02), and hypertriglyceridemia (P = 0.02) were also significantly higher in the İR\} group. Conclusion Insulin resistance is associated with dyslipidemia and \{MBS\} in women with PCOS. Lifestyle modification and insulin-sensitizing agents should be part of the management plan.

El-Mazny, A., N. Abou-Salem, W. El-Khayat, and A. Farouk, "Diagnostic correlation between sonohysterography and hysteroscopy in the assessment of uterine cavity after cesarean section", Middle East Fertility Society Journal, vol. 16, no. 1, pp. 72 - 76, 2011. AbstractWebsite

Background The evolution of sonohysterography (SHG) over the past years has contributed significantly to the assessment of uterine cavity. Objectives To compare \{SHG\} versus the “gold standard” diagnostic hysteroscopy (DH) for the assessment of the uterine cavity in women with previous cesarean section (CS). Design Comparative observational cross-sectional study. Setting Department of Obstetrics and Gynecology, Kasr El-Aini Teaching Hospital, Faculty of Medicine, Cairo University. Subjects Seventy-five women with previous CS(s), complaining of infertility, menstrual disorders or recurrent pregnancy loss. The inclusion criteria were: age between 20 and 35 years; previous 1–3 CS(s); and the duration from the last \{CS\} ranging from 1 to 5 years. Methods Transvaginal \{SHG\} with saline infusion as contrast medium for assessment of the thickness of the scar, filling defect in the scar (niche) and intrauterine adhesions. \{DH\} was performed to confirm different findings. Main outcome measures The findings at \{SHG\} were compared to DH; and the accuracy of \{SHG\} was calculated. Results The scar thickness at \{SHG\} was significantly lower in cases with scar defect at \{DH\} (P = 0.016). \{SHG\} was comparable to \{DH\} as shown by sensitivity, specificity, +ve predictive value, −ve predictive value and overall accuracy of 87%, 100%, 100%, 95% and 96%, respectively, in the diagnosis of scar defect; and 76%, 100%, 100%, 87% and 91%, respectively, in the diagnosis of intrauterine adhesions. Conclusion \{SHG\} is reliable and feasible, and may be recommended as an alternative to \{DH\} for the assessment of the uterine cavity and uterine scar in women with previous CS.